Seeking Alpha

The FDA approves Janssen's (JNJ) Simponi Aria for infusion to treat moderately to severely...

The FDA approves Janssen's (JNJ) Simponi Aria for infusion to treat moderately to severely active rheumatoid arthritis in combination with methotrexate.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|